Riley Jennifer
SEC insider (Form 3/4/5 filer). CIK 0002047607. Chief Strategy Officer at Avalo Therapeutics, Inc. (AVTX). 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 11, 2026. Located in WAYNE, PA.
Companies Riley Jennifer has filed insider reports for
- Avalo Therapeutics, Inc. (AVTX): Officer, Chief Strategy Officer
Riley Jennifer
CIK: 0002047607
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Avalo Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Aug 11, 2026AVTX
Avalo Therapeutics, Inc.
SaleDirect2.7K shares at avg. $19.59$52K - Jun 10, 2026AVTX
Avalo Therapeutics, Inc.
Tax PaymentDirect588 shares at avg. $13.10$8K - May 21, 2026AVTX
Avalo Therapeutics, Inc.
AwardDirect34.2K shares- - Feb 26, 2026AVTX
Avalo Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
95K shares- - Dec 10, 2025AVTX
Avalo Therapeutics, Inc.
Tax PaymentDirect637 shares at avg. $4.10$3K - Jan 1, 2025AVTX
Avalo Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
150K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 11, 2026 | AVTX Avalo Therapeutics, Inc. | Sale | 2,655 | $19.59 | $52,012 | Direct |
| Jun 10, 2026 | AVTX Avalo Therapeutics, Inc. | Tax Payment | 588 | $13.10 | $7,703 | Direct |
| May 21, 2026 | AVTX Avalo Therapeutics, Inc. | Award | 34,200 | - | $0 | Direct |
| Feb 26, 2026 | AVTX Avalo Therapeutics, Inc. | Award Stock Option (Right to Buy) | 95,000 | - | - | Direct |
| Dec 10, 2025 | AVTX Avalo Therapeutics, Inc. | Tax Payment | 637 | $4.10 | $2,612 | Direct |
| Jan 1, 2025 | AVTX Avalo Therapeutics, Inc. | Award Stock Option (Right to Buy) | 150,000 | - | - | Direct |
1-6 of 6 transactions